Frankfurt
12.08.24
15:29 Uhr
0,048 Euro
0,000
0,00 %
0,00 %
1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.08.24 | Biotech Destiny Pharma Tips Into Insolvency in Cash Crisis | 4 | BNN Bloomberg | ||
| 20.08.24 | JP Jenkins Ltd: Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative Antibiotics in Cardio-vascula | 341 | EQS Group (EN) | JP Jenkins Ltd
Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative... ► Artikel lesen | |
| 14.08.24 | JP Jenkins Ltd: Destiny Pharma initiates research to explore XF drug potential for CF | 322 | EQS Group (EN) | JP Jenkins Ltd
Destiny Pharma initiates research to explore XF drug potential for CF 14-Aug-2024 / 11:20 GMT/BST
The issuer is solely responsible for the content of this announcement.
... ► Artikel lesen | |
| 13.08.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.08.2024 | 566 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 13.08.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.08.2024ISIN NameCA44053J4090 HORIZON... ► Artikel lesen | |
| DESTINY PHARMA Aktie jetzt für 0€ handeln | |||||
| 13.08.24 | JP Jenkins Ltd: Destiny Pharma plc shares now trading on JP Jenkins | 233 | EQS Group (EN) | JP Jenkins Ltd
Destiny Pharma plc shares now trading on JP Jenkins 13-Aug-2024 / 09:36 GMT/BST
The issuer is solely responsible for the content of this announcement.
13th Aug... ► Artikel lesen | |
| 13.08.24 | AIM - Cancellation - Destiny Pharma plc | 1 | RNS | ||
| 13.08.24 | XFRA D89: AUSSETZUNG/SUSPENSION | 180 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILDESTINY PHARMA PLC... ► Artikel lesen | |
| 12.08.24 | Destiny Pharma PLC - Last Day of Dealings on AIM | - | RNS | ||
| 06.08.24 | FTSE Russell - Destiny Pharma: Constituent Deletion - Changes in FTSE UK Index Series | 2 | RNS | ||
| 05.08.24 | Small Cap Stocks: Destiny Pharma, Tower Resources, UK Oil & Gas | 3 | The Armchair Trader | ||
| 05.08.24 | Destiny Pharma reports positive findings from XF-73 study | 1 | Sharecast | ||
| 05.08.24 | Destiny Pharma PLC - Director/PDMR Shareholding | 1 | RNS | ||
| 05.08.24 | Destiny Pharma shares fall amid XF-73 fending off MRSA in wounds | 1 | Alliance News | ||
| 05.08.24 | Destiny Pharma PLC - XF-73 prevents bacterial invasion of bloodstream | 1 | RNS | ||
| 31.07.24 | Destiny Pharma PLC - Result of GM and Cancellation of Trading on AIM | 1 | RNS |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CORE ONE LABS | 0,079 | 0,00 % | Prusa gibt Update zum 3D-Drucker CORE One: Erste Auslieferungen stehen bevor | ||
| SKINBIOTHERAPEUTICS | 0,183 | -3,17 % | SkinBioTherapeutics - Result of AGM | ||
| TEMPUS AI | 47,590 | 0,00 % | Tempus AI: KI-App 'olivia' und Pelosis Investition treiben Aktienkurs | ||
| IMMUNOVANT | 23,590 | 0,00 % | Immunovant, Inc. (IMVT): The Biotech Stock with Biggest Upside Potential | ||
| QIAGEN | 45,770 | +0,39 % | Qiagen schüttet clever aus | Bei Qiagen profitieren Anleger nicht nur von verbesserten fundamentalen Aussichten: Das Unternehmen schüttet erneut Kapital über einen Reverse Stock Split aus - insgesamt 300 Mio. US-Dollar. Die Venloer... ► Artikel lesen | |
| ADMA BIOLOGICS | 16,200 | 0,00 % | EWTX Yields Over 300% Returns, ADMA Records 200% Gains - Did You Strike While The Iron Is Hot? | WASHINGTON (dpa-AFX) - Biotech investing is a high-stakes game that may not suit the faint-hearted due to its inherent volatility. However, this sector can offer astronomical returns when investors... ► Artikel lesen | |
| METAGENOMI | 3,360 | +23,30 % | Metagenomi, Inc.: Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones | MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025 NHP Proof-of-Concept Anticipated for Secreted Protein Deficiency Platform in 2025 Leveraging MGX-001 Editing... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 40,420 | 0,00 % | Harmony Biosciences (NASDAQ:HRMY) Earns Buy Rating from HC Wainwright | ||
| EVOTEC | 7,985 | +1,14 % | MIDDAY BRIEFING - Unternehmen und Märkte: MUNICH RE, BERTELSMANN, BORUSSIA DORTMUND, EASYJET, EVOTEC, OLDENBURGISHCHE LANDESBANK, TUIFLY, VOSSLOH | DJ MIDDAY BRIEFING - Unternehmen und Märkte
Der Markt-Überblick am Mittag, zusammengestellt von Dow Jones Newswires:
+++++ AKTIEN- UND ANLEIHEMÄRKTE (13:06 Uhr) +++++
INDEX ... ► Artikel lesen | |
| BIONTECH | 111,40 | -1,07 % | BioNTech-Aktie: Wird 2025 ein gutes Jahr? | Im vergangenen Jahr hat die BioNTech-Aktie nicht gerade mit einer starken Performance geglänzt. Worauf müssen sich Anleger 2025 einstellen? Was spricht für steigende Kurse, was dagegen? Verhaltener... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 7,180 | +4,36 % | Recursion Pharmaceuticals, Inc. (RXRX): Revolutionizing Drug Discovery with AI and Strategic Collaborations for Strong Growth | ||
| JANUX THERAPEUTICS | 40,840 | 0,00 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen | |
| KEROS THERAPEUTICS | 11,435 | 0,00 % | Keros spikes as Teva deal takes effect; Cantor downgrades on trial setback | ||
| ARCELLX | 66,60 | 0,00 % | Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights | REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer... ► Artikel lesen | |
| SPRINGWORKS THERAPEUTICS | 36,330 | 0,00 % | Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A | Goal to accelerate development and commercialization of the lead asset RPT04402 for the treatment of a subset of uterine cancersFinancials include a $13 million upfront payment and potential... ► Artikel lesen |
DESTINY PHARMA PLC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,048 Euro.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DESTINY PHARMA PLC finden Sie auf Wallstreet Online.
